Tevogen Bio Valuation
| TVGN Stock | 1.14 0.03 2.56% |
Today, the company appears to be overvalued. Tevogen Bio Holdings has a current Real Value of USD1.04 per share. The regular price of the company is USD1.14. Our model measures the value of Tevogen Bio Holdings from inspecting the company fundamentals such as Return On Asset of -5.42, shares owned by insiders of 91.35 %, and Number Of Shares Shorted of 1.46 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tevogen Bio's valuation include:
Overvalued
Today
Please note that Tevogen Bio's price fluctuation is abnormally volatile at this time. Calculation of the real value of Tevogen Bio Holdings is based on 3 months time horizon. Increasing Tevogen Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tevogen Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tevogen Stock. However, Tevogen Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.14 | Real 1.04 | Target 4.2 | Hype 1.14 | Naive 1.32 |
The intrinsic value of Tevogen Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tevogen Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tevogen Bio Holdings helps investors to forecast how Tevogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tevogen Bio more accurately as focusing exclusively on Tevogen Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Tevogen Bio's intrinsic value based on its ongoing forecasts of Tevogen Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Tevogen Bio's closest peers.
Tevogen Bio Cash |
|
Tevogen Valuation Trend
Knowing Tevogen Bio's actual value is paramount for traders when making sound investment determinations. Using both Tevogen Bio's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Tevogen Bio Total Value Analysis
Tevogen Bio Holdings is at this time forecasted to have valuation of 206.99 M with market capitalization of 199.56 M, debt of 1.63 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tevogen Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
206.99 M | 199.56 M | 1.63 M |
Tevogen Bio Asset Utilization
One of the ways to look at asset utilization of Tevogen is to check how much profit was generated for every dollar of assets it reports. Tevogen Bio Holdings has a negative utilization of assets of -5.42 %, losing USD0.0542 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Tevogen Bio Holdings shows how discouraging it operates for each dollar spent on its assets.Tevogen Bio Ownership Allocation
Tevogen Bio Holdings shows a total of 175.05 Million outstanding shares. Tevogen Bio Holdings has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 91.35 % of Tevogen Bio outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tevogen Bio Profitability Analysis
Net Loss for the year was (67.33 K) with profit before overhead, payroll, taxes, and interest of 0.About Tevogen Bio Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Tevogen Bio Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Tevogen Bio Holdings based exclusively on its fundamental and basic technical indicators. By analyzing Tevogen Bio's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Tevogen Bio's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tevogen Bio. We calculate exposure to Tevogen Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tevogen Bio's related companies.Tevogen Bio Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 165.4 M |
Tevogen Bio Current Valuation Indicators
Tevogen Bio's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Tevogen Bio's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tevogen Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tevogen Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tevogen Bio's worth.When determining whether Tevogen Bio Holdings is a strong investment it is important to analyze Tevogen Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tevogen Bio's future performance. For an informed investment choice regarding Tevogen Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.